Arcus Biosciences Inc (RCUS) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The Company released a press statement on January 29, 2024, providing updates on its anti-TIGIT clinical development program.
For further insights into RCUS stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
